Proteomics International

We're shifting focus to commercialising our diagnostic tests. With ongoing innovation, a distributor-driven rollout, and new leadership, we’re ready for growth, reimbursement, and global expansion. View article: theage.com.au/business/compa…

We’re pleased to see Proteomes (MDPI) publish an interview with Dr Scott Brigans, Head of Research at @urn:li:organization:2377372, discussing recent work in blood‑based diagnostics for oesophageal cancer. mdpi.com/journal/proteo…

Endometriosis affects 1 in 9 women, yet diagnosis takes years. We're hosting an education evening for healthcare professionals on 26 March focused on practical management & triage in primary care. Free event. CPD applicable. Webinar available. Register: tinyurl.com/MarchEndoGPEve…

Australia goes RED for World Kidney Day. Landmarks across the country were illuminated RED as part of the national awareness initiative led by @KidneyHealth Australia to highlight the growing impact of chronic kidney disease. #WorldKidneyDayAU #KHA #KidneyCodeRed

World Kidney Day highlights the impact of chronic kidney disease in Australia. Proteomics International has researched protein biomarkers associated with kidney disease risk, including clinical evaluation of the Promarker®D assay. #WorldKidneyDay #KidneyCodeRed #Awareness

Recent stories in the media have been deeply distressing for many in the endometriosis community. We acknowledge how difficult it can be to read or hear accounts of painful experiences and concerns about care, and we recognise the courage of those who have shared their stories.

High-plex discovery is easy. Clinical translation is the challenge. Promarker® supports biomarker validation for clinical research using targeted mass spectrometry assays, quantitative data, and ISO-accredited laboratory workflows. Enquire here: proteomics.com.au/submit-your-se…

We’re pleased to appoint David Morris as CEO & Managing Director of Proteomics International Laboratories Ltd (ASX: PIQ), effective 19th Jan 2026. David brings deep global MedTech leadership as we accelerate commercialisation of the Promarker® pipeline.

Proteomics International secures Canadian patent for breakthrough esophageal cancer blood test. Patents now cover: 🇺🇸 🇨🇦 🇪🇺 🇦🇺 🇨🇳 🇭🇰 90% of EAC cases are detected too late. This test is a game-changer for early diagnosis. Full details: investor.proteomics.com.au/investors/asx/

Media coverage this week has highlighted Proteomics International’s proteomics-based testing approaches for assessing diabetic kidney disease risk, including their relevance to Indigenous communities.   More info: proteomics.com.au/promarkerd-home Article: smh.com.au/business/compa…

Firefighters face a 62% higher risk of esophageal cancer. This is a public health crisis.   Early detection matters. Promarker®Eso is part of our commitment to advancing predictive diagnostics for high risk communities.   Story: abc.net.au/news/2025-12-1…

🧪 C-Terminal Lysine Truncation in Antibodies Sensitive MS-based quantification of C-terminal lysine loss on mAbs—supporting batch consistency & biosimilar comparability, aligned with ICH Q6B. 🔗 hubs.la/Q03Y6lMg0 #Biologics #Biosimilars #MassSpectrometry

Let Us Do the Proteomics for you Advance your precision medicine projects with: ✔️ Biomarker discovery ✔️ PK+Biomarker Validation ✔️ Clinical-grade proteomic insights 👉 You focus on the science — we’ll handle the proteomics. #Proteomics #Biomarkers #MassSpec #DrugDevelopment

Medtech company @ProteomicsI has landed a major US breakthrough, with Medicare setting a US$390.75 reimbursement price for its next-gen #PromarkerD kidney disease test, paving the way for national clinical uptake. $PIQ #BULLSNBEARSWA #ASX @smh smh.com.au/business/compa…

🌟 Reliable Biomarkers Powered by Proteomics Our ISO 17025–accredited workflows & Promarker® platform deliver accurate, reproducible insights for diagnostics, drug development & patient stratification. #Biomarkers #PrecisionMedicine hubs.la/Q03Vm4XX0

Thank you to the hosts & sponsors: @endometriosiswa, Hey Sister, & Luna Palace Cinemas. Let’s continue raising awareness and supporting the work that brings hope, equity, and better care to everyone impacted by this disease 💛

No one should have to suffer in silence for years before receiving proper care. @ProteomicsI is committed to advancing innovative health solutions that empower people with endometriosis to access care sooner.

Last night, members of the @ProteomicsI team attended a special screening of BELOW THE BEST, a powerful documentary following 4 individuals on their urgent search for answers to mysterious symptoms - endometriosis.

Stronger insights for better biologics. N-terminal pyroglutamination quantitation with high-res MS—ideal for biosimilar comparability, manufacturing optimisation, stability checks & QA monitoring. #Biologics #MassSpectrometry #Proteomics #Biotech